Evaluation of POLE/POLD1 Variants as Potential Biomarkers for Immune Checkpoint Inhibitor Treatment Outcomes.
作者信息
Rousseau Benoît, Vidal Joana, Diaz Luis A
机构信息
Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Medical Oncology Department, Hospital del Mar Medical Research Institute, Centro de Investigación Biomédica en Red Cáncer, Instituto de Salud Carlos III, Barcelona, Spain.
出版信息
JAMA Oncol. 2020 Apr 1;6(4):589-590. doi: 10.1001/jamaoncol.2020.0065.
PMID:32134429
Abstract
摘要
Zotero 插件